Shares of Amedisys have gone up nearly 8% since markets closed Friday afternoon, thanks to chatter about a potential private equity buyout. Shares in the Baton Rouge home health company closed at $31.31 Friday afternoon; they were trading at $33.76 as of early this afternoon. CRT Capital Group has said there was talk about a buyout but called it “highly unlikely” because of ongoing investigations. Amedisys and several other home health businesses are being investigated by the U.S. Senate Committee on Finance, the Department of Justice and the Securities and Exchange Commission over allegations the companies boosted the number of home therapy visits made to their respective patients in order to trigger higher Medicare reimbursements. Amedisys has strongly denied charges it changed home therapy visits to get more money. An Amedisys spokesman refused to comment on a potential buyout, saying the company makes it a policy not to comment on rumors.
Amedisys shares up on buyout rumors
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
